{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:21:15Z","timestamp":1777321275823,"version":"3.51.4"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00109-024-02512-x","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T15:59:06Z","timestamp":1735574346000},"page":"187-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Deciphering metabolic shifts in Gaucher disease type 1: a multi-omics study"],"prefix":"10.1007","volume":"103","author":[{"given":"Franklin","family":"Ducatez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Plichet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Lesueur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Belmatoug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Marret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumeya","family":"Bekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-2678","authenticated-orcid":false,"given":"Abdellah","family":"Tebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"2512_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A (2017) A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci 18:441","journal-title":"Int J Mol Sci"},{"key":"2512_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ymgme.2016.11.006","volume":"120","author":"PK Mistry","year":"2017","unstructured":"Mistry PK, Lopez G, Schiffmann R, Barton NW, Weinreb NJ, Sidransky E (2017) Gaucher disease: progress and ongoing challenges. Mol Genet Metab 120:8\u201321. https:\/\/doi.org\/10.1016\/j.ymgme.2016.11.006","journal-title":"Mol Genet Metab"},{"issue":"19","key":"2512_CR3","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.3390\/ijms21197159","volume":"21","author":"S Revel-Vilk","year":"2020","unstructured":"Revel-Vilk S, Fuller M, Zimran A (2020) Value of glucosylsphingosine (Lyso-Gb1) as a biomarker in Gaucher disease: a systematic literature review. Int J Mol Sci 21(19):7159. https:\/\/doi.org\/10.3390\/ijms21197159","journal-title":"Int J Mol Sci"},{"key":"2512_CR4","first-page":"273","volume":"14","author":"E Sidransky","year":"2012","unstructured":"Sidransky E (2012) Gaucher disease: insights from a rare Mendelian disorder. Discov Med 14:273\u2013281","journal-title":"Discov Med"},{"key":"2512_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","volume":"89","author":"O Neudorfer","year":"1996","unstructured":"Neudorfer O, Giladi N, Elstein D, Abrahamov A, Turezkite T, Aghai E, Reches A, Bembi B, Zimran A (1996) Occurrence of Parkinson\u2019s syndrome in type I Gaucher disease. QJM 89:691\u2013694. https:\/\/doi.org\/10.1093\/qjmed\/89.9.691","journal-title":"QJM"},{"key":"2512_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/mgme.2001.3201","volume":"73","author":"N Tayebi","year":"2001","unstructured":"Tayebi N, Callahan M, Madike V, Stubblefield BK, Orvisky E, Krasnewich D, Fillano JJ, Sidransky E (2001) Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 73:313\u2013321. https:\/\/doi.org\/10.1006\/mgme.2001.3201","journal-title":"Mol Genet Metab"},{"key":"2512_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/s1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K, Rosenbaum H, Schiffmann R, Bembi B, Sidransky E (2003) Gaucher disease with Parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104\u2013109. https:\/\/doi.org\/10.1016\/s1096-7192(03)00071-4","journal-title":"Mol Genet Metab"},{"key":"2512_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ymgme.2020.01.009","volume":"129","author":"S Nair","year":"2020","unstructured":"Nair S, Bar N, Xu ML, Dhodapkar M, Mistry PK (2020) Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy. Mol Genet Metab 129:286\u2013291. https:\/\/doi.org\/10.1016\/j.ymgme.2020.01.009","journal-title":"Mol Genet Metab"},{"key":"2512_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa1508808","volume":"374","author":"S Nair","year":"2016","unstructured":"Nair S, Branagan AR, Liu J, Boddupalli CS, Mistry PK, Dhodapkar MV (2016) Clonal immunoglobulin against lysolipids in the origin of myeloma. N Engl J Med 374:555\u2013561. https:\/\/doi.org\/10.1056\/NEJMoa1508808","journal-title":"N Engl J Med"},{"key":"2512_CR10","doi-asserted-by":"publisher","first-page":"e98259","DOI":"10.1172\/jci.insight.98259","volume":"3","author":"S Nair","year":"2018","unstructured":"Nair S, Sng J, Boddupalli CS, Seckinger A, Chesi M, Fulciniti M, Zhang L, Rauniyar N, Lopez M, Neparidze N et al (2018) Antigen-mediated regulation in monoclonal gammopathies and myeloma. JCI Insight 3:e98259. https:\/\/doi.org\/10.1172\/jci.insight.98259","journal-title":"JCI Insight"},{"key":"2512_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/tra.12587","volume":"19","author":"B Cabukusta","year":"2018","unstructured":"Cabukusta B, Neefjes J (2018) Mechanisms of lysosomal positioning and movement. Traffic (Copenhagen, Denmark) 19:761\u2013769. https:\/\/doi.org\/10.1111\/tra.12587","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"2512_CR12","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1242\/jcs.196287","volume":"129","author":"J Pu","year":"2016","unstructured":"Pu J, Guardia CM, Keren-Kaplan T, Bonifacino JS (2016) Mechanisms and functions of lysosome positioning. J Cell Sci 129:4329\u20134339. https:\/\/doi.org\/10.1242\/jcs.196287","journal-title":"J Cell Sci"},{"key":"2512_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1750-1172-7-77","volume":"7","author":"J Stirnemann","year":"2012","unstructured":"Stirnemann J, Vigan M, Hamroun D, Heraoui D, Rossi-Semerano L, Berger MG, Rose C, Camou F, de Roux-Serratrice C, Grosbois B et al (2012) The French Gaucher\u2019s disease registry: clinical characteristics, complications and treatment of 562 patients. Orphanet J Rare Dis 7:77. https:\/\/doi.org\/10.1186\/1750-1172-7-77","journal-title":"Orphanet J Rare Dis"},{"key":"2512_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","volume":"90","author":"MJ Allen","year":"1997","unstructured":"Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM (1997) Pro-inflammatory cytokines and the pathogenesis of Gaucher\u2019s disease: increased release of interleukin-6 and interleukin-10. QJM 90:19\u201325. https:\/\/doi.org\/10.1093\/qjmed\/90.1.19","journal-title":"QJM"},{"key":"2512_CR15","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/mds.28525","volume":"36","author":"J Galper","year":"2021","unstructured":"Galper J, Balwani M, Fahn S, Waters C, Krohn L, Gan-Or Z, Dzamko N, Alcalay RN (2021) Cytokines and Gaucher biomarkers in glucocerebrosidase carriers with and without Parkinson disease. Mov Disord 36:1451\u20131455. https:\/\/doi.org\/10.1002\/mds.28525","journal-title":"Mov Disord"},{"key":"2512_CR16","unstructured":"Trevor H, Tibshirani R, Narasimhan B, Chu G (2022) Impute: impute: imputation for microarray data"},{"key":"2512_CR17","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/bioinformatics\/btm069","volume":"23","author":"W Stacklies","year":"2007","unstructured":"Stacklies W, Redestig H, Scholz M, Walther D, Selbig J (2007) pcaMethods\u2013a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23:1164\u20131167. https:\/\/doi.org\/10.1093\/bioinformatics\/btm069","journal-title":"Bioinformatics"},{"key":"2512_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"2512_CR19","doi-asserted-by":"publisher","first-page":"147798","DOI":"10.1016\/j.brainres.2022.147798","volume":"1780","author":"L Francelle","year":"2022","unstructured":"Francelle L, Mazzulli JR (2022) Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson\u2019s disease. Brain Res 1780:147798. https:\/\/doi.org\/10.1016\/j.brainres.2022.147798","journal-title":"Brain Res"},{"issue":"18","key":"2512_CR20","doi-asserted-by":"publisher","first-page":"10387","DOI":"10.3390\/ijms231810387","volume":"23","author":"L Lopez de Frutos","year":"2022","unstructured":"Lopez de Frutos L, Almeida F, Murillo-Saich J, Conceicao VA, Guma M, Queheberger O, Giraldo P, Miltenberger-Miltenyi G (2022) Serum phospholipid profile changes in Gaucher disease and Parkinson\u2019s disease. Int J Mol Sci 23(18):10387. https:\/\/doi.org\/10.3390\/ijms231810387","journal-title":"Int J Mol Sci"},{"key":"2512_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","volume":"81","author":"B Wang","year":"2019","unstructured":"Wang B, Tontonoz P (2019) Phospholipid remodeling in physiology and disease. Annu Rev Physiol 81:165\u2013188","journal-title":"Annu Rev Physiol"},{"key":"2512_CR22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbalip.2011.09.009","volume":"1821","author":"LK Cole","year":"2012","unstructured":"Cole LK, Vance JE, Vance DE (2012) Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim Biophys Acta 1821:754\u2013761. https:\/\/doi.org\/10.1016\/j.bbalip.2011.09.009","journal-title":"Biochim Biophys Acta"},{"key":"2512_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12860-014-0043-3","volume":"15","author":"C Moessinger","year":"2014","unstructured":"Moessinger C, Klizaite K, Steinhagen A, Philippou-Massier J, Shevchenko A, Hoch M, Ejsing CS, Thiele C (2014) Two different pathways of phosphatidylcholine synthesis, the Kennedy pathway and the Lands cycle, differentially regulate cellular triacylglycerol storage. BMC Cell Biol 15:43. https:\/\/doi.org\/10.1186\/s12860-014-0043-3","journal-title":"BMC Cell Biol"},{"key":"2512_CR24","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1091\/mbc.01-11-0540","volume":"13","author":"AL Henneberry","year":"2002","unstructured":"Henneberry AL, Wright MM, McMaster CR (2002) The major sites of cellular phospholipid synthesis and molecular determinants of fatty acid and lipid head group specificity. Mol Biol Cell 13:3148\u20133161. https:\/\/doi.org\/10.1091\/mbc.01-11-0540","journal-title":"Mol Biol Cell"},{"key":"2512_CR25","doi-asserted-by":"publisher","first-page":"e47990","DOI":"10.7554\/eLife.47990","volume":"8","author":"K Petkevicius","year":"2019","unstructured":"Petkevicius K, Virtue S, Bidault G, Jenkins B, Cubuk C, Morgantini C, Aouadi M, Dopazo J, Serlie MJ, Koulman A, Vidal-Puig A (2019) Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity. Elife 8:e47990. https:\/\/doi.org\/10.7554\/eLife.47990","journal-title":"Elife"},{"key":"2512_CR26","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1042\/bj3200905","volume":"320","author":"MW Lee","year":"1996","unstructured":"Lee MW, Bakovic M, Vance DE (1996) Overexpression of phosphatidylethanolamine <i>N<\/i>-methyltransferase 2 in CHO-K1 cells does not attenuate the activity of the CDP-choline pathway for phosphatidylcholine biosynthesis. Biochem J 320:905\u2013910. https:\/\/doi.org\/10.1042\/bj3200905","journal-title":"Biochem J"},{"key":"2512_CR27","doi-asserted-by":"publisher","first-page":"20423","DOI":"10.1074\/jbc.r110.134452","volume":"285","author":"EB Vitner","year":"2010","unstructured":"Vitner EB, Platt FM, Futerman AH (2010) Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 285:20423\u201320427. https:\/\/doi.org\/10.1074\/jbc.r110.134452","journal-title":"J Biol Chem"},{"issue":"2","key":"2512_CR28","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.15252\/emmm.202012836","volume":"13","author":"G Parenti","year":"2021","unstructured":"Parenti G, Medina DL, Ballabio A (2021) The rapidly evolving view of lysosomal storage diseases. EMBO Molecular Medicine 13(2):e12836. https:\/\/doi.org\/10.15252\/emmm.202012836","journal-title":"EMBO Molecular Medicine"},{"key":"2512_CR29","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1074\/jbc.M114.551051","volume":"289","author":"FJ Dufort","year":"2014","unstructured":"Dufort FJ, Gumina MR, Ta NL, Tao Y, Heyse SA, Scott DA, Richardson AD, Seyfried TN, Chiles TC (2014) Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. J Biol Chem 289:7011\u20137024. https:\/\/doi.org\/10.1074\/jbc.M114.551051","journal-title":"J Biol Chem"},{"key":"2512_CR30","doi-asserted-by":"publisher","first-page":"e8595","DOI":"10.1002\/rcm.8595","volume":"34","author":"J Miletic Vukajlovic","year":"2020","unstructured":"Miletic Vukajlovic J, Drakulic D, Pejic S, Ilic TV, Stefanovic A, Petkovic M, Schiller J (2020) Increased plasma phosphatidylcholine\/lysophosphatidylcholine ratios in patients with Parkinson\u2019s disease. Rapid Commun Mass Spectrom 34:e8595. https:\/\/doi.org\/10.1002\/rcm.8595","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2512_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-019-1553-y","volume":"15","author":"OD Rangel-Huerta","year":"2019","unstructured":"Rangel-Huerta OD, Pastor-Villaescusa B, Gil A (2019) Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies. Metabolomics 15:1\u201331. https:\/\/doi.org\/10.1007\/s11306-019-1553-y","journal-title":"Metabolomics"},{"key":"2512_CR32","doi-asserted-by":"publisher","first-page":"19819","DOI":"10.1038\/s41598-022-24406-z","volume":"12","author":"K Saito","year":"2022","unstructured":"Saito K, Gemma A, Tatsumi K, Hattori N, Ushiki A, Tsushima K, Saito Y, Abe M, Horimasu Y, Kashiwada T et al (2022) Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease. Sci Rep 12:19819. https:\/\/doi.org\/10.1038\/s41598-022-24406-z","journal-title":"Sci Rep"},{"key":"2512_CR33","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/nu10091254","volume":"10","author":"A Gonzalez-Granda","year":"2018","unstructured":"Gonzalez-Granda A, Damms-Machado A, Basrai M, Bischoff S (2018) Changes in plasma acylcarnitine and lysophosphatidylcholine levels following a high-fructose diet: a targeted metabolomics study in healthy women. Nutrients 10:1254. https:\/\/doi.org\/10.3390\/nu10091254","journal-title":"Nutrients"},{"key":"2512_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.toxrep.2016.08.004","volume":"3","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Pence L, Yan K, Gill P, Luo C, Letzig LG, Simpson PM, Kearns GL, Beger RD, James LP (2016) Targeted metabolomic profiling indicates structure-based perturbations in serum phospholipids in children with acetaminophen overdose. Toxicol Rep 3:747\u2013755. https:\/\/doi.org\/10.1016\/j.toxrep.2016.08.004","journal-title":"Toxicol Rep"},{"key":"2512_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/acel.12409","volume":"15","author":"E Aflaki","year":"2016","unstructured":"Aflaki E, Moaven N, Borger DK, Lopez G, Westbroek W, Chae JJ, Marugan J, Patnaik S, Maniwang E, Gonzalez AN, Sidransky E (2016) Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages. Aging Cell 15:77\u201388. https:\/\/doi.org\/10.1111\/acel.12409","journal-title":"Aging Cell"},{"key":"2512_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","volume":"90","author":"M Allen","year":"1997","unstructured":"Allen M, Myer B, Khokher A, Rushton N, Cox T (1997) Pro-inflammatory cytokines and the pathogenesis of Gaucher\u2019s disease: increased release of interleukin-6 and interleukin-10. QJM: Int J Med 90:19\u201325","journal-title":"QJM: Int J Med"},{"key":"2512_CR37","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","volume":"1772","author":"MJ Van Breemen","year":"2007","unstructured":"Van Breemen MJ, De Fost M, Voerman JS, Laman JD, Boot RG, Maas M, Hollak CE, Aerts JM, Rezaee F (2007) Increased plasma macrophage inflammatory protein (MIP)-1\u03b1 and MIP-1\u03b2 levels in type 1 Gaucher disease. Biochim Biophys Acta (BBA) - Mol Basis Dis 1772:788\u2013796","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"2512_CR38","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1038\/s41598-019-42584-1","volume":"9","author":"A \u0141ugowska","year":"2019","unstructured":"\u0141ugowska A, Hetma\u0144czyk-Sawicka K, Iwanicka-Nowicka R, Fogtman A, Cie\u015bla J, Purzycka-Olewiecka JK, Sitarska D, P\u0142oski R, Filocamo M, Lualdi S et al (2019) Gene expression profile in patients with Gaucher disease indicates activation of inflammatory processes. Sci Rep 9:6060. https:\/\/doi.org\/10.1038\/s41598-019-42584-1","journal-title":"Sci Rep"},{"key":"2512_CR39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ymgme.2012.04.020","volume":"106","author":"MK Pandey","year":"2012","unstructured":"Pandey MK, Rani R, Zhang W, Setchell K, Grabowski GA (2012) Immunological cell type characterization and Th1\u2013Th17 cytokine production in a mouse model of Gaucher disease. Mol Genet Metab 106:310\u2013322. https:\/\/doi.org\/10.1016\/j.ymgme.2012.04.020","journal-title":"Mol Genet Metab"},{"key":"2512_CR40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A et al (2017) A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci 18:441. https:\/\/doi.org\/10.3390\/ijms18020441","journal-title":"Int J Mol Sci"},{"key":"2512_CR41","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","volume":"1772","author":"MJ van Breemen","year":"2007","unstructured":"van Breemen MJ, de Fost M, Voerman JS, Laman JD, Boot RG, Maas M, Hollak CE, Aerts JM, Rezaee F (2007) Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease. Biochim Biophys Acta 1772:788\u2013796. https:\/\/doi.org\/10.1016\/j.bbadis.2007.04.002","journal-title":"Biochim Biophys Acta"},{"key":"2512_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bcmd.2015.05.009","volume":"55","author":"JM Mucci","year":"2015","unstructured":"Mucci JM, Cuello MF, Kisinovsky I, Larroude M, Delpino MV, Rozenfeld PA (2015) Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: implication for bone pathology. Blood Cells Mol Dis 55:134\u2013143. https:\/\/doi.org\/10.1016\/j.bcmd.2015.05.009","journal-title":"Blood Cells Mol Dis"},{"key":"2512_CR43","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/jcm9051325","volume":"9","author":"A Tebani","year":"2020","unstructured":"Tebani A, Mauhin W, Abily-Donval L, Lesueur C, Berger MG, Nadjar Y, Berger J, Benveniste O, Lamari F, Lafor\u00eat P et al (2020) A proteomics-based analysis reveals predictive biological patterns in Fabry disease. J Clin Med 9:1325. https:\/\/doi.org\/10.3390\/jcm9051325","journal-title":"J Clin Med"},{"key":"2512_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fcell.2020.00223","volume":"8","author":"Y Tan","year":"2020","unstructured":"Tan Y, Qiao Y, Chen Z, Liu J, Guo Y, Tran T, Tan KS, Wang DY, Yan Y (2020) FGF2, an immunomodulatory factor in asthma and chronic obstructive pulmonary disease (COPD). Front Cell Dev Biol 8:223. https:\/\/doi.org\/10.3389\/fcell.2020.00223","journal-title":"Front Cell Dev Biol"},{"key":"2512_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F et al (2020) FGF\/FGFR signaling in health and disease. Signal Transduct Target Ther 5:181. https:\/\/doi.org\/10.1038\/s41392-020-00222-7","journal-title":"Signal Transduct Target Ther"},{"key":"2512_CR46","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ajcn.82.2.342","volume":"82","author":"ME Suliman","year":"2005","unstructured":"Suliman ME, Qureshi AR, Stenvinkel P, Pecoits-Filho R, Barany P, Heimburger O, Anderstam B, Rodriguez Ayala E, Divino Filho JC, Alvestrand A, Lindholm B (2005) Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. Am J Clin Nutr 82:342\u2013349. https:\/\/doi.org\/10.1093\/ajcn.82.2.342","journal-title":"Am J Clin Nutr"},{"key":"2512_CR47","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM (2000) M-1\/M-2 macrophages and the Th1\/Th2 paradigm. J Immunol 164:6166\u20136173. https:\/\/doi.org\/10.4049\/jimmunol.164.12.6166","journal-title":"J Immunol"},{"key":"2512_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00403-017-1760-1","volume":"309","author":"A Ottas","year":"2017","unstructured":"Ottas A, Fishman D, Okas TL, Kingo K, Soomets U (2017) The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease. Arch Dermatol Res 309:519\u2013528. https:\/\/doi.org\/10.1007\/s00403-017-1760-1","journal-title":"Arch Dermatol Res"},{"key":"2512_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/2040622318759282","volume":"9","author":"TC Chan","year":"2018","unstructured":"Chan TC, Hawkes JE, Krueger JG (2018) Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment. Ther Adv Chronic Dis 9:111\u2013119. https:\/\/doi.org\/10.1177\/2040622318759282","journal-title":"Ther Adv Chronic Dis"},{"key":"2512_CR50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cbpa.2019.10.006","volume":"53","author":"J Aerts","year":"2019","unstructured":"Aerts J, Kuo CL, Lelieveld LT, Boer DEC, van der Lienden MJC, Overkleeft HS, Artola M (2019) Glycosphingolipids and lysosomal storage disorders as illustrated by Gaucher disease. Curr Opin Chem Biol 53:204\u2013215. https:\/\/doi.org\/10.1016\/j.cbpa.2019.10.006","journal-title":"Curr Opin Chem Biol"},{"key":"2512_CR51","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10545-012-9529-3","volume":"36","author":"A Zimmermann","year":"2013","unstructured":"Zimmermann A, Grigorescu-Sido P, Rossmann H, Lackner KJ, Drugan C, Al Khzouz C, Bucerzan S, Nascu I, Zimmermann T, Leucuta D, Weber MM (2013) Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study. J Inherit Metab Dis 36:555\u2013563. https:\/\/doi.org\/10.1007\/s10545-012-9529-3","journal-title":"J Inherit Metab Dis"},{"key":"2512_CR52","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bcmd.2016.10.016","volume":"68","author":"MC Matta","year":"2018","unstructured":"Matta MC, Vairo F, Torres LC, Schwartz I (2018) Could enzyme replacement therapy promote immune tolerance in Gaucher disease type 1? Blood Cells Mol Dis 68:200\u2013202. https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.016","journal-title":"Blood Cells Mol Dis"},{"key":"2512_CR53","doi-asserted-by":"publisher","first-page":"100667","DOI":"10.1016\/j.ymgmr.2020.100667","volume":"25","author":"RV Kartha","year":"2020","unstructured":"Kartha RV, Terluk MR, Brown R, Travis A, Mishra UR, Rudser K, Lau H, Jarnes JR, Cloyd JC, Weinreb NJ (2020) Patients with Gaucher disease display systemic oxidative stress dependent on therapy status. Mol Genet Metab Rep 25:100667. https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100667","journal-title":"Mol Genet Metab Rep"},{"key":"2512_CR54","doi-asserted-by":"publisher","first-page":"38299","DOI":"10.1038\/srep38299","volume":"6","author":"S Suzuki","year":"2016","unstructured":"Suzuki S, Kodera Y, Saito T, Fujimoto K, Momozono A, Hayashi A, Kamata Y, Shichiri M (2016) Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress. Sci Rep 6:38299. https:\/\/doi.org\/10.1038\/srep38299","journal-title":"Sci Rep"},{"key":"2512_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1023\/a:1007638025856","volume":"16","author":"A Vanella","year":"2000","unstructured":"Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, Barcellona ML (2000) L-propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol 16:99\u2013104. https:\/\/doi.org\/10.1023\/a:1007638025856","journal-title":"Cell Biol Toxicol"},{"key":"2512_CR56","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fcell.2017.00110","volume":"5","author":"N Plotegher","year":"2017","unstructured":"Plotegher N, Duchen MR (2017) Crosstalk between lysosomes and mitochondria in Parkinson\u2019s disease. Front Cell Dev Biol 5:110. https:\/\/doi.org\/10.3389\/fcell.2017.00110","journal-title":"Front Cell Dev Biol"},{"key":"2512_CR57","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/jcm9082596","volume":"9","author":"KM Stepien","year":"2020","unstructured":"Stepien KM, Roncaroli F, Turton N, Hendriksz CJ, Roberts M, Heaton RA, Hargreaves I (2020) Mechanisms of mitochondrial dysfunction in lysosomal storage disorders: a review. J Clin Med 9:2596. https:\/\/doi.org\/10.3390\/jcm9082596","journal-title":"J Clin Med"},{"key":"2512_CR58","doi-asserted-by":"publisher","first-page":"13555","DOI":"10.18632\/aging.103462","volume":"12","author":"ZR Jarrell","year":"2020","unstructured":"Jarrell ZR, Smith MR, Hu X, Orr M, Liu KH, Quyyumi AA, Jones DP, Go Y-M (2020) Plasma acylcarnitine levels increase with healthy aging. Aging 12:13555\u201313570. https:\/\/doi.org\/10.18632\/aging.103462","journal-title":"Aging"},{"key":"2512_CR59","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","volume":"25","author":"JP Bonnefont","year":"2004","unstructured":"Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J (2004) Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25:495\u2013520. https:\/\/doi.org\/10.1016\/j.mam.2004.06.004","journal-title":"Mol Aspects Med"},{"key":"2512_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.mito.2021.10.008","volume":"62","author":"WHG Hubens","year":"2022","unstructured":"Hubens WHG, Vallbona-Garcia A, de Coo IFM, van Tienen FHJ, Webers CAB, Smeets HJM, Gorgels T (2022) Blood biomarkers for assessment of mitochondrial dysfunction: an expert review. Mitochondrion 62:187\u2013204. https:\/\/doi.org\/10.1016\/j.mito.2021.10.008","journal-title":"Mitochondrion"},{"key":"2512_CR61","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3390\/ijms21093374","volume":"21","author":"N Garrido-P\u00e9rez","year":"2020","unstructured":"Garrido-P\u00e9rez N, Vela-Sebasti\u00e1n A, L\u00f3pez-Gallardo E, Emperador S, Iglesias E, Meade P, Jim\u00e9nez-Mallebrera C, Montoya J, Bayona-Bafaluy MP, Ruiz-Pesini E (2020) Oxidative phosphorylation dysfunction modifies the cell secretome. Int J Mol Sci 21:3374. https:\/\/doi.org\/10.3390\/ijms21093374","journal-title":"Int J Mol Sci"},{"issue":"260\u2013276","key":"2512_CR62","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.devcel.2020.11.016","volume":"56","author":"OB Davis","year":"2021","unstructured":"Davis OB, Shin HR, Lim CY, Wu EY, Kukurugya M, Maher CF, Perera RM, Ordonez MP, Zoncu R (2021) NPC1-mTORC1 signaling couples cholesterol sensing to organelle homeostasis and is a targetable pathway in Niemann-Pick type C. Dev Cell 56(260\u2013276):e267. https:\/\/doi.org\/10.1016\/j.devcel.2020.11.016","journal-title":"Dev Cell"},{"key":"2512_CR63","doi-asserted-by":"publisher","first-page":"dmm038596","DOI":"10.1242\/dmm.038596","volume":"12","author":"RA Brown","year":"2019","unstructured":"Brown RA, Voit A, Srikanth MP, Thayer JA, Kingsbury TJ, Jacobson MA, Lipinski MM, Feldman RA, Awad O (2019) mTOR hyperactivity mediates lysosomal dysfunction in Gaucher\u2019s disease iPSC-neuronal cells. Dis Model Mech 12:dmm038596. https:\/\/doi.org\/10.1242\/dmm.038596","journal-title":"Dis Model Mech"},{"key":"2512_CR64","doi-asserted-by":"publisher","first-page":"e0210617","DOI":"10.1371\/journal.pone.0210617","volume":"14","author":"MM Ivanova","year":"2019","unstructured":"Ivanova MM, Changsila E, Iaonou C, Goker-Alpan O (2019) Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases. PLoS ONE 14:e0210617. https:\/\/doi.org\/10.1371\/journal.pone.0210617","journal-title":"PLoS ONE"},{"key":"2512_CR65","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.1523\/jneurosci.4527-15.2016","volume":"36","author":"KJ Kinghorn","year":"2016","unstructured":"Kinghorn KJ, Gr\u00f6nke S, Castillo-Quan JI, Woodling NS, Li L, Sirka E, Gegg M, Mills K, Hardy J, Bjedov I, Partridge L (2016) A<i>Drosophila<\/i>model of neuronopathic Gaucher disease demonstrates lysosomal-autophagic defects and altered mTOR signalling and is functionally rescued by rapamycin. J Neurosci 36:11654\u201311670. https:\/\/doi.org\/10.1523\/jneurosci.4527-15.2016","journal-title":"J Neurosci"},{"key":"2512_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.12703\/P6-52","volume":"6","author":"R Puertollano","year":"2014","unstructured":"Puertollano R (2014) mTor and lysosome regulation. F1000Prime Rep 6:52","journal-title":"F1000Prime Rep"},{"key":"2512_CR67","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/1873-3468.12711","volume":"591","author":"M Linke","year":"2017","unstructured":"Linke M, Fritsch SD, Sukhbaatar N, Hengstschl\u00e4ger M, Weichhart T (2017) <scp>mTORC<\/scp>1 and <scp>mTORC<\/scp>2 as regulators of cell metabolism in immunity. FEBS Lett 591:3089\u20133103. https:\/\/doi.org\/10.1002\/1873-3468.12711","journal-title":"FEBS Lett"},{"key":"2512_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13023-019-1211-5","volume":"14","author":"M Kaluzna","year":"2019","unstructured":"Kaluzna M, Trzeciak I, Ziemnicka K, Machaczka M, Ruchala M (2019) Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review. Orphanet J Rare Dis 14:275. https:\/\/doi.org\/10.1186\/s13023-019-1211-5","journal-title":"Orphanet J Rare Dis"},{"key":"2512_CR69","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, Griffiths JR, Chung Y-L, Schulze A (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8:224\u2013236. https:\/\/doi.org\/10.1016\/j.cmet.2008.07.007","journal-title":"Cell Metab"},{"key":"2512_CR70","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1073\/pnas.0912059107","volume":"107","author":"J Ecker","year":"2010","unstructured":"Ecker J, Liebisch G, Englmaier M, Grandl M, Robenek H, Schmitz G (2010) Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci 107:7817\u20137822. https:\/\/doi.org\/10.1073\/pnas.0912059107","journal-title":"Proc Natl Acad Sci"},{"key":"2512_CR71","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.immuni.2017.04.028","volume":"46","author":"RG Jones","year":"2017","unstructured":"Jones RG, Pearce EJ (2017) MenTORing immunity: mTOR signaling in the development and function of tissue-resident immune cells. Immunity 46:730\u2013742. https:\/\/doi.org\/10.1016\/j.immuni.2017.04.028","journal-title":"Immunity"},{"key":"2512_CR72","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3390\/cells9092044","volume":"9","author":"G Pastor-Fern\u00e1ndez","year":"2020","unstructured":"Pastor-Fern\u00e1ndez G, Mariblanca IR, Navarro MN (2020) Decoding IL-23 signaling cascade for new therapeutic opportunities. Cells 9:2044. https:\/\/doi.org\/10.3390\/cells9092044","journal-title":"Cells"},{"key":"2512_CR73","doi-asserted-by":"publisher","first-page":"e59083","DOI":"10.1371\/journal.pone.0059083","volume":"8","author":"M-T Lau","year":"2013","unstructured":"Lau M-T, So W-K, Leung PCK (2013) Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K\/Akt\/mTOR and MAPK\/ERK signaling in ovarian cancer cells. PLoS ONE 8:e59083. https:\/\/doi.org\/10.1371\/journal.pone.0059083","journal-title":"PLoS ONE"},{"key":"2512_CR74","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd KM, Yang J, Shen MH, Sampson JR, Tee AR (2015) mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34:2239\u20132250. https:\/\/doi.org\/10.1038\/onc.2014.164","journal-title":"Oncogene"},{"key":"2512_CR75","doi-asserted-by":"publisher","first-page":"53269","DOI":"10.18632\/oncotarget.10756","volume":"7","author":"S Wang","year":"2016","unstructured":"Wang S, Lu J, You Q, Huang H, Chen Y, Liu K (2016) The mTOR\/AP-1\/VEGF signaling pathway regulates vascular endothelial cell growth. Oncotarget 7:53269\u201353276. https:\/\/doi.org\/10.18632\/oncotarget.10756","journal-title":"Oncotarget"},{"key":"2512_CR76","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.3389\/fimmu.2018.02786","volume":"9","author":"C Buerger","year":"2018","unstructured":"Buerger C (2018) Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target. Front Immunol 9:2786. https:\/\/doi.org\/10.3389\/fimmu.2018.02786","journal-title":"Front Immunol"},{"key":"2512_CR77","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1038\/s41598-017-04826-y","volume":"7","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Jing Y, Qiao J, Luan B, Wang X, Wang L, Song Z (2017) Activation of the mTOR signaling pathway is required for asthma onset. Sci Rep 7:4532. https:\/\/doi.org\/10.1038\/s41598-017-04826-y","journal-title":"Sci Rep"},{"key":"2512_CR78","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature25023","volume":"552","author":"H Yang","year":"2017","unstructured":"Yang H, Jiang X, Li B, Yang HJ, Miller M, Yang A, Dhar A, Pavletich NP (2017) Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 552:368\u2013373. https:\/\/doi.org\/10.1038\/nature25023","journal-title":"Nature"},{"key":"2512_CR79","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/sctm.20-0386","volume":"10","author":"MP Srikanth","year":"2021","unstructured":"Srikanth MP, Jones JW, Kane M, Awad O, Park TS, Zambidis ET, Feldman RA (2021) Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1. Stem Cells Transl Med 10:1081\u20131094. https:\/\/doi.org\/10.1002\/sctm.20-0386","journal-title":"Stem Cells Transl Med"},{"key":"2512_CR80","doi-asserted-by":"publisher","first-page":"11746","DOI":"10.1016\/s0021-9258(19)38461-3","volume":"265","author":"PS Sohal","year":"1990","unstructured":"Sohal PS, Cornell RB (1990) Sphingosine inhibits the activity of rat liver CTP:phosphocholine cytidylyltransferase. J Biol Chem 265:11746\u201311750. https:\/\/doi.org\/10.1016\/s0021-9258(19)38461-3","journal-title":"J Biol Chem"},{"key":"2512_CR81","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1073\/pnas.1400768111","volume":"111","author":"PK Mistry","year":"2014","unstructured":"Mistry PK, Liu J, Sun L, Chuang WL, Yuen T, Yang R, Lu P, Zhang K, Li J, Keutzer J et al (2014) Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease. Proc Natl Acad Sci U S A 111:4934\u20134939. https:\/\/doi.org\/10.1073\/pnas.1400768111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2512_CR82","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/ijms20051149","volume":"20","author":"S-H Law","year":"2019","unstructured":"Law S-H, Chan M-L, Marathe GK, Parveen F, Chen C-H, Ke L-Y (2019) An updated review of lysophosphatidylcholine metabolism in human diseases. Int J Mol Sci 20:1149. https:\/\/doi.org\/10.3390\/ijms20051149","journal-title":"Int J Mol Sci"},{"key":"2512_CR83","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/onc.2012.47","volume":"32","author":"Z-H Wen","year":"2013","unstructured":"Wen Z-H, Su Y-C, Lai P-L, Zhang Y, Xu Y-F, Zhao A, Yao G-Y, Jia C-H, Lin J, Xu S et al (2013) Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis. Oncogene 32:160\u2013170. https:\/\/doi.org\/10.1038\/onc.2012.47","journal-title":"Oncogene"},{"key":"2512_CR84","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW (2021) Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther 6:94. https:\/\/doi.org\/10.1038\/s41392-020-00443-w","journal-title":"Signal Transduct Target Ther"},{"key":"2512_CR85","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P et al (2011) TFEB links autophagy to lysosomal biogenesis. Science 332:1429\u20131433. https:\/\/doi.org\/10.1126\/science.1204592","journal-title":"Science"},{"key":"2512_CR86","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4161\/auto.19653","volume":"8","author":"JA Martina","year":"2012","unstructured":"Martina JA, Chen Y, Gucek M, Puertollano R (2012) MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8:903\u2013914. https:\/\/doi.org\/10.4161\/auto.19653","journal-title":"Autophagy"},{"key":"2512_CR87","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ymgme.2012.04.020","volume":"106","author":"MK Pandey","year":"2012","unstructured":"Pandey MK, Rani R, Zhang W, Setchell K, Grabowski GA (2012) Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease. Mol Genet Metab 106:310\u2013322. https:\/\/doi.org\/10.1016\/j.ymgme.2012.04.020","journal-title":"Mol Genet Metab"},{"key":"2512_CR88","doi-asserted-by":"publisher","first-page":"23004","DOI":"10.1074\/jbc.m113.495754","volume":"289","author":"T Rahbek-Clemmensen","year":"2014","unstructured":"Rahbek-Clemmensen T, Bay T, Eriksen J, Gether U, J\u00f8rgensen TN (2014) The serotonin transporter undergoes constitutive internalization and is primarily sorted to late endosomes and lysosomal degradation. J Biol Chem 289:23004\u201323019. https:\/\/doi.org\/10.1074\/jbc.m113.495754","journal-title":"J Biol Chem"},{"key":"2512_CR89","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.3390\/ijms22157931","volume":"22","author":"N Liu","year":"2021","unstructured":"Liu N, Sun S, Wang P, Sun Y, Hu Q, Wang X (2021) The mechanism of secretion and metabolism of gut-derived 5-hydroxytryptamine. Int J Mol Sci 22:7931. https:\/\/doi.org\/10.3390\/ijms22157931","journal-title":"Int J Mol Sci"},{"key":"2512_CR90","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","volume":"432","author":"X Hou","year":"2020","unstructured":"Hou X, Watzlawik JO, Fiesel FC, Springer W (2020) Autophagy in Parkinson\u2019s disease. J Mol Biol 432:2651\u20132672. https:\/\/doi.org\/10.1016\/j.jmb.2020.01.037","journal-title":"J Mol Biol"},{"key":"2512_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0154-3","volume":"12","author":"TE Moors","year":"2017","unstructured":"Moors TE, Hoozemans JJM, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin M-C, Van De Berg WDJ (2017) Therapeutic potential of autophagy-enhancing agents in Parkinson\u2019s disease. Mol Neurodegener 12:1\u201318. https:\/\/doi.org\/10.1186\/s13024-017-0154-3","journal-title":"Mol Neurodegener"},{"key":"2512_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgmr.2015.05.001","volume":"4","author":"AS Mello","year":"2015","unstructured":"Mello AS, da Silva GC, de Souza MF, da Silva MN, Wohlenberg MF, Marinho JP, Dani C, Funchal C, Coelho JC (2015) Oxidative stress parameters of Gaucher disease type I patients. Mol Genet Metab Rep 4:1\u20135. https:\/\/doi.org\/10.1016\/j.ymgmr.2015.05.001","journal-title":"Mol Genet Metab Rep"},{"key":"2512_CR93","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.3390\/ijms23169189","volume":"23","author":"SA Sahasrabudhe","year":"2022","unstructured":"Sahasrabudhe SA, Terluk MR, Rudser KD, Cloyd JC, Kartha RV (2022) Biological variation in peripheral inflammation and oxidative stress biomarkers in individuals with Gaucher disease. Int J Mol Sci 23:9189. https:\/\/doi.org\/10.3390\/ijms23169189","journal-title":"Int J Mol Sci"},{"key":"2512_CR94","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12011-019-01709-3","volume":"193","author":"H Mozafari","year":"2020","unstructured":"Mozafari H, Khatami S, Kiani A, Rahimi Z, Vaisi-Raygani A, Afsharnaderi A, Alaei MR (2020) Oxidative stress parameters, trace elements, and lipid profile in Iranian patients with Gaucher disease. Biol Trace Elem Res 193:130\u2013137. https:\/\/doi.org\/10.1007\/s12011-019-01709-3","journal-title":"Biol Trace Elem Res"},{"key":"2512_CR95","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cca.2008.06.018","volume":"396","author":"MJ van Breemen","year":"2008","unstructured":"van Breemen MJ, Aerts JM, Sprenger RR, Speijer D (2008) Potential artefacts in proteome analysis of plasma of Gaucher patients due to protease abnormalities. Clin Chim Acta; Int J Clin Chem 396:26\u201332. https:\/\/doi.org\/10.1016\/j.cca.2008.06.018","journal-title":"Clin Chim Acta; Int J Clin Chem"},{"key":"2512_CR96","first-page":"227","volume":"23","author":"T LR","year":"1956","unstructured":"LR T, SUNA H, JJ C (1956) Elevation of serum acid phosphatase in Gaucher\u2019s disease. J Mt Sinai Hosp N Y 23:227\u2013229","journal-title":"J Mt Sinai Hosp N Y"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02512-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T21:02:14Z","timestamp":1738789334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02512-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02512-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The French national biological collection (ELODIE-MG) housed at the CRB-Auvergne in Clermont-Ferrand (France) under the scientific responsibility of the French Gaucher disease expert group (Comit\u00e9 d\u2019Evaluation du Traitement de la maladie de Gaucher; CETG). All authors have read the journal\u2019s authorship agreement, and the manuscript has been reviewed by and approved by all named authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}